827 related articles for article (PubMed ID: 25504837)
41. Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging.
Schleich N; Sibret P; Danhier P; Ucakar B; Laurent S; Muller RN; Jérôme C; Gallez B; Préat V; Danhier F
Int J Pharm; 2013 Apr; 447(1-2):94-101. PubMed ID: 23485340
[TBL] [Abstract][Full Text] [Related]
42. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.
Ma W; Li G; Wang J; Yang W; Zhang Y; Conti PS; Chen K
Amino Acids; 2014 Dec; 46(12):2721-32. PubMed ID: 25182731
[TBL] [Abstract][Full Text] [Related]
43. Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics.
Prasad R; Aiyer S; Chauhan DS; Srivastava R; Selvaraj K
Nanoscale; 2016 Feb; 8(8):4537-46. PubMed ID: 26753966
[TBL] [Abstract][Full Text] [Related]
44. Near-Infrared Heptamethine Cyanine Based Iron Oxide Nanoparticles for Tumor Targeted Multimodal Imaging and Photothermal Therapy.
Lee S; George Thomas R; Ju Moon M; Ju Park H; Park IK; Lee BI; Yeon Jeong Y
Sci Rep; 2017 May; 7(1):2108. PubMed ID: 28522841
[TBL] [Abstract][Full Text] [Related]
45. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
46. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy.
Zhang M; Cao Y; Wang L; Ma Y; Tu X; Zhang Z
ACS Appl Mater Interfaces; 2015 Mar; 7(8):4650-8. PubMed ID: 25672225
[TBL] [Abstract][Full Text] [Related]
47. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
Jang MK; Jeong YI; Nah JW
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
[TBL] [Abstract][Full Text] [Related]
48. Photoacoustic-based nanomedicine for cancer diagnosis and therapy.
Sim C; Kim H; Moon H; Lee H; Chang JH; Kim H
J Control Release; 2015 Apr; 203():118-25. PubMed ID: 25701310
[TBL] [Abstract][Full Text] [Related]
49. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
[TBL] [Abstract][Full Text] [Related]
50. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
[TBL] [Abstract][Full Text] [Related]
51. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
[TBL] [Abstract][Full Text] [Related]
52. A transferrin-target magnetic/fluorescent dual-mode probe significantly enhances the diagnosis of non-small cell lung cancer.
Cai J; Gu B; Cao F; Liu S
Oncotarget; 2016 Jun; 7(26):40047-40059. PubMed ID: 27223075
[TBL] [Abstract][Full Text] [Related]
53. An Acid-Triggered Degradable and Fluorescent Nanoscale Drug Delivery System with Enhanced Cytotoxicity to Cancer Cells.
An J; Dai X; Wu Z; Zhao Y; Lu Z; Guo Q; Zhang X; Li C
Biomacromolecules; 2015 Aug; 16(8):2444-54. PubMed ID: 26213802
[TBL] [Abstract][Full Text] [Related]
54. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
Lee JE; Lee N; Kim T; Kim J; Hyeon T
Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
[TBL] [Abstract][Full Text] [Related]
55. Facile phase transfer of hydrophobic Fe
Lin K; Cao Y; Zheng D; Li Q; Liu H; Yu P; Li J; Xue Y; Wu M
J Mater Chem B; 2020 Feb; 8(6):1202-1211. PubMed ID: 31942915
[TBL] [Abstract][Full Text] [Related]
56. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
57. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging.
Hu J; Qian Y; Wang X; Liu T; Liu S
Langmuir; 2012 Jan; 28(4):2073-82. PubMed ID: 22047551
[TBL] [Abstract][Full Text] [Related]
58. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
[TBL] [Abstract][Full Text] [Related]
59. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release.
Ferber S; Baabur-Cohen H; Blau R; Epshtein Y; Kisin-Finfer E; Redy O; Shabat D; Satchi-Fainaro R
Cancer Lett; 2014 Sep; 352(1):81-9. PubMed ID: 24614283
[TBL] [Abstract][Full Text] [Related]
60. Formation of oligonucleotide-gated silica shell-coated Fe₃O₄-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform.
Li WP; Liao PY; Su CH; Yeh CS
J Am Chem Soc; 2014 Jul; 136(28):10062-75. PubMed ID: 24953310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]